Literature DB >> 23863452

The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption.

Huining He1, Jianyong Sheng, Allan E David, Young Min Kwon, Jian Zhang, Yongzhuo Huang, Jianxin Wang, Victor C Yang.   

Abstract

Although oral delivery of insulin offers a number of unmatched advantages, it nevertheless is beset by the poor permeability of insulin molecules through the epithelial cell membranes of the intestinal mucosal layer. We previously reported the development of low molecular weight protamine (LMWP) as a non-toxic yet potent cell-penetrating peptide, of which via covalent linkage was capable of translocating protein cargos through the membranes of almost all cell types. It is therefore hypothesized that LMWP could be practically employed as a safe and effective tool to deliver insulin across the intestinal mucosal membrane, thereby augmenting its absorption through the GI tract. However, formulating 1:1 monomeric insulin/LMWP conjugate presents a tall order of challenge, as the acidic insulin and basic LMWP would automatically form tight aggregates through electrostatic interactions. In this paper, we developed an innovative conjugation strategy to solve this problem, by using succinimidyl-[(N-maleimidopropionamido)-polyethyleneglycol] ester (NHS-PEG-MAL) as an intermediate cross-linker during the coupling process. Both SDS-PAGE and MALDI-TOF mass spectroscopy confirmed the formation of a homogenous, monomeric (1:1 ratio) insulin/LMWP conjugate without encountering the conventional problem of substrate aggregation. Cell culture studies demonstrated that transport of the Insulin-PEG-LMWP conjugate across the intestinal mucosal monolayer was augmented by almost five-folds compared to native insulin. Furthermore, results from the in situ loop absorption tests in rats showed that systemic pharmacological bioavailability of insulin was significantly enhanced after its conjugation with LMWP. Overall, the presented chemical conjugation with LMWP could offer a reliable and safe means to improve the intestinal permeability of therapeutic peptides/proteins, shedding light of the possibility for their effective oral delivery. Published by Elsevier Ltd.

Entities:  

Keywords:  Cell-penetrating peptide; Insulin; Intestinal absorption; Low molecular weight protamine; Monomeric conjugation; Permeation enhancement

Mesh:

Substances:

Year:  2013        PMID: 23863452      PMCID: PMC3766633          DOI: 10.1016/j.biomaterials.2013.06.047

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  42 in total

1.  A novel approach using functional peptides for efficient intestinal absorption of insulin.

Authors:  Mariko Morishita; Noriyasu Kamei; Jumpei Ehara; Koichi Isowa; Kozo Takayama
Journal:  J Control Release       Date:  2006-12-29       Impact factor: 9.776

Review 2.  A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.

Authors:  Mei-Chin Chen; Kiran Sonaje; Ko-Jie Chen; Hsing-Wen Sung
Journal:  Biomaterials       Date:  2011-09-17       Impact factor: 12.479

3.  Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.

Authors:  Fang-Yi Su; Kun-Ju Lin; Kiran Sonaje; Shiaw-Pyng Wey; Tzu-Chen Yen; Yi-Cheng Ho; Nilendu Panda; Er-Yuan Chuang; Barnali Maiti; Hsing-Wen Sung
Journal:  Biomaterials       Date:  2012-01-11       Impact factor: 12.479

4.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

5.  Polymer integrity related absorption mechanism of superporous hydrogel containing interpenetrating polymer networks for oral delivery of insulin.

Authors:  Lichen Yin; Jieying Ding; Jing Zhang; Chunbai He; Cui Tang; Chunhua Yin
Journal:  Biomaterials       Date:  2010-02-08       Impact factor: 12.479

Review 6.  PEGylation, successful approach to drug delivery.

Authors:  Francesco M Veronese; Gianfranco Pasut
Journal:  Drug Discov Today       Date:  2005-11-01       Impact factor: 7.851

7.  Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats.

Authors:  C Q Xia; J Wang; W C Shen
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

8.  Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study.

Authors:  Yoon Jeong Park; Li-Chien Chang; Jun Feng Liang; Cheol Moon; Chong-Pyoung Chung; Victor C Yang
Journal:  FASEB J       Date:  2005-07-20       Impact factor: 5.191

9.  Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans.

Authors:  Staffan Sandgren; Fang Cheng; Mattias Belting
Journal:  J Biol Chem       Date:  2002-08-05       Impact factor: 5.157

10.  Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and provides an alternative to HPLC in characterization of protein PEGylation.

Authors:  Chunyang Zheng; Chunyang Y Zheng; Guanghui Ma; Zhiguo Su
Journal:  Electrophoresis       Date:  2007-08       Impact factor: 3.535

View more
  10 in total

Review 1.  Chemically modified peptides and proteins - critical considerations for oral delivery.

Authors:  Stephen T Buckley; František Hubálek; Ulrik Lytt Rahbek
Journal:  Tissue Barriers       Date:  2016-03-03

2.  PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study.

Authors:  Meong Cheol Shin; Jian Zhang; Kyoung Ah Min; Huining He; Allan E David; Yongzhuo Huang; Victor C Yang
Journal:  Pharm Res       Date:  2015-02-21       Impact factor: 4.200

3.  Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapy.

Authors:  Meong Cheol Shin; Jian Zhang; Kyoung Ah Min; Kyuri Lee; Cheol Moon; Joseph P Balthasar; Victor C Yang
Journal:  J Control Release       Date:  2014-09-07       Impact factor: 9.776

Review 4.  Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application.

Authors:  Huining He; Junxiao Ye; Yinsong Wang; Quan Liu; Hee Sun Chung; Young Min Kwon; Meong Cheol Shin; Kyuri Lee; Victor C Yang
Journal:  J Control Release       Date:  2013-12-27       Impact factor: 9.776

5.  High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA.

Authors:  Junxiao Ye; Ergang Liu; Junbo Gong; Jianxin Wang; Yongzhuo Huang; Huining He; Victor C Yang
Journal:  Theranostics       Date:  2017-06-25       Impact factor: 11.556

6.  Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin.

Authors:  Hae-Duck Bae; Joohyun Lee; Kyu-Yeon Jun; Youngjoo Kwon; Kyunglim Lee
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 7.  Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins.

Authors:  Ying Han; Zhonggao Gao; Liqing Chen; Lin Kang; Wei Huang; Mingji Jin; Qiming Wang; You Han Bae
Journal:  Acta Pharm Sin B       Date:  2019-01-10       Impact factor: 11.413

8.  Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat.

Authors:  Patrik Lundquist; Georgiy Khodus; Zhigao Niu; Lungile Nomcebo Thwala; Fiona McCartney; Ivailo Simoff; Ellen Andersson; Ana Beloqui; Aloise Mabondzo; Sandra Robla; Dominic-Luc Webb; Per M Hellström; Åsa V Keita; Eduardo Sima; Noemi Csaba; Magnus Sundbom; Veronique Preat; David J Brayden; Maria Jose Alonso; Per Artursson
Journal:  ACS Nano       Date:  2022-08-23       Impact factor: 18.027

9.  Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect.

Authors:  Juntao Yin; Yantao Hou; Yuyun Yin; Xiaoyong Song
Journal:  Int J Nanomedicine       Date:  2017-12-06

10.  Protamine and BSA-dextran complex emulsion improves oral bioavailability and anti-tumor efficacy of paclitaxel.

Authors:  Guangrui Xu; Xiaoyan Bao; Ping Yao
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.